Jeffrey Leroy Larson's most recent trade in Tvardi Therapeutics Inc. was a trade of 10,820 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Jeffrey Leroy Larson | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 10,820 | 10,820 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Jeffrey Leroy Larson | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 16,764 | 16,764 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Jeffrey Leroy Larson | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 5,364 | 5,364 | - | - | Employee Stock Option (right to buy) |